Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct;8(20):1324.
doi: 10.21037/atm-20-2995.

Transbronchial cryobiopsy for diffuse parenchymal lung diseases: evidence that demands a (favorable) verdict

Matthew Aboudara  1 , Fabien Maldonado  2
Affiliations
Editorial

Transbronchial cryobiopsy for diffuse parenchymal lung diseases: evidence that demands a (favorable) verdict

Matthew Aboudara et al. Ann Transl Med. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform (available at http://dx.doi.org/10.21037/atm-20-2995). FM reports receiving unrestricted educational grant from ERBE. The other author has no conflicts of interest to declare.

Comment on

References

    1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias . This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304. 10.1164/ajrccm.165.2.ats01 - DOI - PubMed
    1. Flaherty KR, King TE, Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004;170:904-10. 10.1164/rccm.200402-147OC - DOI - PubMed
    1. King TE, Bradford WZ, Castro-Bernardini S, et al. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. New England Journal of Medicine 2014;370:2083-92. 10.1056/NEJMoa1402582 - DOI - PubMed
    1. Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-82. 10.1056/NEJMoa1402584 - DOI - PubMed
    1. Yagihashi K, Huckleberry J, Colby TV, et al. Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia. Eur Respir J 2016;47:1189-97. 10.1183/13993003.01680-2015 - DOI - PubMed